Teva Pharmaceutical Industries Limited (TEVJF)

Market Cap	39.81B +109.7%
Revenue (ttm)	17.35B +4.4%
Net Income	1.57B
EPS	1.34
Shares Out	n/a
PE Ratio	25.44
Forward PE	15.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	220
Open	30.34
Previous Close	n/a
Day's Range	30.34 - 37.00
52-Week Range	14.00 - 37.00
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About TEVJF

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 32,008
• Stock Exchange: OTCMKTS
• Ticker Symbol: TEVJF